Search research articles
Contact Us
Filters
Showing results (201-210 of 271) with videos related to
Page
of 28
Sort By:
Frontiers in Public Health
|
July 5, 2024
High-income ZIP codes in New York City demonstrate higher case rates during off-peak COVID-19 waves
Steven T L Tung, Mosammat M Perveen, Kirsten N Wohlars, et al.
Journal of the Association for Information Science and Technology
|
September 2, 2025
Sharing Information about Health-Related Resources: Observations from a Community Resource Referral Intervention Trial in a Predominantly African American/Black Community
Stacy Tessler Lindau, Jennifer Makelarski, Emily Abramsohn, et al.
Breast Cancer Research and Treatment
|
May 23, 1998
Progesterone receptor variants found in breast cells repress transcription by wild-type receptors
J K Richer, C A Lange, A M Wierman, et al.
Health Affairs (Project Hope)
|
April 7, 2025
An Urban Farm-Anchored Produce Prescription Program's Impacts On Weight Reduction
Kaitlyn M Fruin, Elizabeth L Tung, Jean M Franczyk, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
July 27, 1999
Tamoxifen resistant breast cancer: coregulators determine the direction of transcription by antagonist-occupied steroid receptors
G S Takimoto, J D Graham, T A Jackson, et al.
Ciba Foundation Symposium
|
January 1, 1995
Surprises with antiprogestins: novel mechanisms of progesterone receptor action
K B Horwitz, C A Sartorius, A R Hovland, et al.
Pediatric Radiology
|
April 1, 2021
Screening of cancer predisposition syndromes
Haifa Al-Sarhani, Ravi V Gottumukkala, Angelo Don S Grasparil, et al.
Skeletal Radiology
|
September 10, 2024
Clinical, imaging and pathological features of extraskeletal myxoid chondrosarcoma
Amine El Kandoussi, Yin P Hung, Eric L Tung, et al.
Japanese Journal of Clinical Oncology
|
March 12, 1999
ESHAP as salvage therapy for refractory non-Hodgkin's lymphoma: Taiwan experience
W S Wang, T J Chiou, J H Liu, et al.
Japanese Journal of Clinical Oncology
|
December 9, 1997
Treatment of previously treated metastatic breast cancer by mitoxantrone and 48-hour continuous infusion of high-dose 5-FU and leucovorin (MFL): low palliative benefit and high treatment-related toxicity
C C Yen, S L Tung, R K Hsieh, et al.
Page
of 28
Search research articles
Search
Showing results (201-210 of 271) with videos related to
Sort By:
Page
of 28
Frontiers in Public Health
|
July 5, 2024
High-income ZIP codes in New York City demonstrate higher case rates during off-peak COVID-19 waves
Steven T L Tung, Mosammat M Perveen, Kirsten N Wohlars, et al.
Journal of the Association for Information Science and Technology
|
September 2, 2025
Sharing Information about Health-Related Resources: Observations from a Community Resource Referral Intervention Trial in a Predominantly African American/Black Community
Stacy Tessler Lindau, Jennifer Makelarski, Emily Abramsohn, et al.
Breast Cancer Research and Treatment
|
May 23, 1998
Progesterone receptor variants found in breast cells repress transcription by wild-type receptors
J K Richer, C A Lange, A M Wierman, et al.
Health Affairs (Project Hope)
|
April 7, 2025
An Urban Farm-Anchored Produce Prescription Program's Impacts On Weight Reduction
Kaitlyn M Fruin, Elizabeth L Tung, Jean M Franczyk, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
July 27, 1999
Tamoxifen resistant breast cancer: coregulators determine the direction of transcription by antagonist-occupied steroid receptors
G S Takimoto, J D Graham, T A Jackson, et al.
Ciba Foundation Symposium
|
January 1, 1995
Surprises with antiprogestins: novel mechanisms of progesterone receptor action
K B Horwitz, C A Sartorius, A R Hovland, et al.
Pediatric Radiology
|
April 1, 2021
Screening of cancer predisposition syndromes
Haifa Al-Sarhani, Ravi V Gottumukkala, Angelo Don S Grasparil, et al.
Skeletal Radiology
|
September 10, 2024
Clinical, imaging and pathological features of extraskeletal myxoid chondrosarcoma
Amine El Kandoussi, Yin P Hung, Eric L Tung, et al.
Japanese Journal of Clinical Oncology
|
March 12, 1999
ESHAP as salvage therapy for refractory non-Hodgkin's lymphoma: Taiwan experience
W S Wang, T J Chiou, J H Liu, et al.
Japanese Journal of Clinical Oncology
|
December 9, 1997
Treatment of previously treated metastatic breast cancer by mitoxantrone and 48-hour continuous infusion of high-dose 5-FU and leucovorin (MFL): low palliative benefit and high treatment-related toxicity
C C Yen, S L Tung, R K Hsieh, et al.
Page
of 28